Diaceutics (LON:DXRX) Trading 0.4% Higher

Shares of Diaceutics PLC (LON:DXRX) traded up 0.4% during mid-day trading on Thursday . The company traded as high as GBX 122 ($1.55) and last traded at GBX 120.50 ($1.53). 53,456 shares traded hands during mid-day trading, a decline of 51% from the average session volume of 108,730 shares. The stock had previously closed at GBX 120 ($1.52).

Analyst Ratings Changes

Separately, Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 150 ($1.90) price objective on shares of Diaceutics in a research report on Tuesday, May 21st.

Diaceutics Stock Up 0.4 %

The stock has a 50-day moving average of GBX 115.27 and a 200-day moving average of GBX 103.14. The company has a quick ratio of 9.92, a current ratio of 7.99 and a debt-to-equity ratio of 3.07. The company has a market cap of £101.74 million, a PE ratio of 10,500.00 and a beta of 0.47.

Insider Buying and Selling at Diaceutics

In other news, insider Graham Paterson purchased 39,934 shares of the stock in a transaction on Wednesday, May 22nd. The shares were acquired at an average price of GBX 129 ($1.64) per share, for a total transaction of £51,514.86 ($65,349.31). Company insiders own 34.54% of the company’s stock.

Diaceutics Company Profile

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.